Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients

Yan Zhao, Hailiang Li, Wei Bai, Jueshi Liu, Weifu Lv, Sonia Sahu, Sheng Guan, Xiao Qin, Wenhui Wang, Weixin Ren, Wei Mu, Weidong Guo, Shanzhi Gu, Yilong Ma, Zhanxin Yin, Wengang Guo, Wenjun Wang, Yongji Wang, Rafael Duran, Daiming FanZhuoli Zhang, Guohong Han*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

22 Scopus citations

Fingerprint

Dive into the research topics of 'Early sorafenib-related adverse events predict therapy response of TACE plus sorafenib: A multicenter clinical study of 606 HCC patients'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Neuroscience